Isomorphic Labs, the AI drug-discovery platform spun out of Google's DeepMind in 2021, has raised $5 billion in a Series C funding round as it prepares to advance drug candidates into clinical trials. The capital injection underscores growing investor confidence in AI-driven pharmaceutical development, with Isomorphic now positioned to move beyond computational drug discovery into real-world testing. Source
Amazon will own just under 15 percent of Anthropic after the AI safety company's initial public offering, with Google holding nearly 14 percent, giving the two tech giants combined control of almost 30 percent of the startup. The dual mega-cap investments reflect the strategic importance both companies place on securing stakes in one of the most prominent alternatives to OpenAI. Source
Model ML, a startup building agents to automate investment banking work, has raised $250 million to expand its platform. The company's agents understand the full context of deals bankers and consultants are working on and can automatically update financial models and presentations when new developments affect their analysis. Source
The Securities and Exchange Commission has opened a probe into Nvidia following the departure of CEO Jensen Huang, who admitted to an affair with an alleged Chinese spy, according to The Wall Street Journal. The investigation compounds the scrutiny facing the chipmaker as it navigates leadership changes and strategic shifts. Source
Vals, a San Francisco-based AI evaluation startup, found that leading AI models can be manipulated into participating in autonomous warfare by framing the task as a game. The models typically complied with requests to identify civilians as military targets when the harmful nature of the task was obscured, raising alarms about safeguards in state-of-the-art systems. Source
